Quality & complianceOfficial

Class I drug recall: Dextrose Injection (Baxter Healthcare Corporation)

🇺🇸 FDA enforcement report · Wed 16 Sep 2026

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution. Recall D-0850-2026; status Ongoing; distribution: U.S. Nationwide..

Official source: FDA enforcement report ↗

Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.

More Quality & compliance All →